US Broker Ratings

Replimune Group, Inc. (REPL) Stock Analysis: Evaluating an 86% Potential Upside with Robust Analyst Ratings

Replimune Group, Inc. (NASDAQ: REPL), a promising player in the biotechnology sector, is capturing attention with its innovative approach to cancer treatment through oncolytic immunotherapies. Headquartered..

ArriVent BioPharma, Inc. (AVBP)

⚠️ No article content returned.

..

SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 100.99% Potential Upside in the Healthcare Sector

Investors seeking exposure in the healthcare sector, particularly in medical devices, may find SI-BONE, Inc. (NASDAQ: SIBN) an intriguing prospect. With its innovative approach to orthopedic..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 55.79% Potential Upside in Biotech Innovations

Bicara Therapeutics Inc. (NASDAQ: BCAX) is making waves in the biotechnology sector, offering investors a compelling opportunity with its groundbreaking approach to cancer treatment. With a..

GH Research PLC (GHRS): Investor Outlook and 165% Potential Upside Amidst a Robust Pipeline

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is capturing investor attention with its promising pipeline in the burgeoning field of..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech with 43.67% Potential Upside in the Healthcare Sector

Spyre Therapeutics, Inc. (SYRE), a dynamic player in the biotechnology sector, is capturing the attention of the investment community with its promising developments in the treatment..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotechnology Powerhouse with Over 107% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is making waves in the biotechnology sector with its innovative approach to treating central nervous system (CNS) disorders. As a..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Navigating a 50% Upside Potential with Promising Cancer Therapies

Arcus Biosciences, Inc. (NASDAQ: RCUS) is carving a niche in the biotechnology sector with its pioneering approach to cancer therapies. As a clinical-stage biopharmaceutical company, Arcus..

Geron Corporation (GERN) Stock Analysis: A 119% Potential Upside in Biotech Investment

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company with a focus on oncology therapeutics, presents a compelling case for investors keen on biotechnology prospects. With a market..

Pharvaris N.V. (PHVS) Investor Outlook: 76% Potential Upside in Biotech Innovation

Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is making waves in the healthcare sector with its pioneering approach to treating rare diseases. With a market capitalization..

CareDx, Inc. (CDNA) Stock Analysis: 40.99% Potential Upside Sparks Investor Interest

CareDx, Inc. (NASDAQ: CDNA), a key player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with a notable potential upside of 40.99%...

SAP SE (SAP) Stock Report: Is a 61.69% Upside in the Cards for This Technology Giant?

SAP SE (SAP), a cornerstone in the technology sector known for its comprehensive suite of enterprise application solutions, is currently trading at $183.74 USD. This current..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a Potential 28.74% Upside in the Advertising Sector

DoubleVerify Holdings, Inc. (NYSE: DV) is making waves in the advertising sector with its innovative media effectiveness platforms. As investors look for promising opportunities in the..

Similarweb Ltd. (SMWB) Investor Outlook: Exploring Nearly 98% Upside Potential

For investors eyeing opportunities in the technology sector, Similarweb Ltd. (NASDAQ: SMWB), a digital intelligence provider based in Israel, presents an intriguing case. With its current..

Diebold Nixdorf (DBD) Investor Outlook: Exploring a 35% Upside Potential

As investors continue to seek out opportunities in the technology sector, Diebold Nixdorf Incorporated (NYSE: DBD) presents an intriguing case. With a market capitalization of $2.56..

Autodesk, Inc. (ADSK) Stock Analysis: Unpacking the 33.51% Potential Upside for Investors

Autodesk, Inc. (ADSK), a titan in the technology sector, stands out in the software application industry with its impressive suite of 3D design and engineering solutions...

Paylocity Holding Corporation (PCTY) Stock Analysis: A Promising 54.72% Upside Potential

Paylocity Holding Corporation (NASDAQ: PCTY), a prominent player in the cloud-based human capital management and payroll software sector, presents an intriguing opportunity for investors, especially given..

Paychex, Inc. (PAYX) Stock Analysis: Evaluating a 26% Potential Upside Amidst Strong Dividends

Investors considering exploring opportunities within the technology sector might find Paychex, Inc. (NASDAQ: PAYX) a compelling candidate, particularly given its potential upside and robust dividend yield...

Paycom Software, Inc. (PAYC) Stock Analysis: Unveiling a 22.85% Potential Upside Amid Technology Sector Volatility

Amid the rapidly evolving landscape of the technology sector, Paycom Software, Inc. (NASDAQ: PAYC) stands out as a leading provider of cloud-based human capital management (HCM)..

Digital Turbine, Inc. (APPS) Stock Analysis: A 168% Potential Upside Amidst Market Challenges

Digital Turbine, Inc. (NASDAQ: APPS) operates within the fast-paced technology sector, specifically in the software application industry. With a current market capitalization of $390.87 million, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds